Form 4: Macrogenics Director William K. Heiden Reports Stock Transactions
SEC Form 4 Filing
Director William K. Heiden reports the vesting and disposal of 4,500 restricted stock units (RSUs) of Macrogenics Inc. on May 20, 2024.
Summary
- On May 20, 2024, William K. Heiden, a director of Macrogenics Inc., reported transactions involving the company's stock.
- Heiden disposed of 4,500 shares of common stock upon the vesting of restricted stock units (RSUs).
- The RSUs vested on May 20, 2024, one day before the company's annual meeting.
- The initial RSU grant was approved by the Board of Directors on May 31, 2023.
- Each RSU represents the right to receive one share of Macrogenics Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative implications.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is a common practice in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disclosure of stock transactions by a company insider.
Key Dates
| Date | Description |
|---|---|
| 05/31/2023 | The restricted stock unit (RSU) grant was approved by the Board of Directors. |
| 05/20/2024 | RSUs vested and 4,500 shares of common stock were disposed of. |
| 05/21/2024 | Issuer's 2024 Annual Meeting of Stockholders. |
| 05/22/2024 | Date of signature by Attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.